Autonomix Medical, Inc. Common Stock (AMIX NASDAQ) stock market data APIs
$1.5221
0.01(0.7%)
as of July 10, 2025
Try our APIs with
free plan!
Autonomix Medical, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Prev. Close
1.5221
Open
1.5313
High
1.5915
Low
1.4595
52 wk Range
1.14-42.4
Market Cap
4 199 K
Shares Outstanding
2 780 K
EPS
-0.74
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Autonomix Medical, Inc. Common Stock data using free add-ons & libraries
Get Autonomix Medical, Inc. Common Stock Fundamental Data
Autonomix Medical, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -11 405 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-29
- EPS/Forecast: -1.24
Get Autonomix Medical, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Autonomix Medical, Inc. Common Stock News
New
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-ta...
Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study
Expansion of study into additional indications doubles the potential addressable market beyond pancreatic cancer pain PoC 2 phase builds on early success and positive results demonstrated in PoC 1 in...
Autonomix receives US patent for nerve-sensing medical technology
THE WOODLANDS, TX - Autonomix Medical, Inc. (NASDAQ:AMIX), a medical technology company with a current market capitalization of $3.5 million and strong liquidity position evidenced by a current ratio ...
Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology
Autonomix Medical, Inc. Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need indications Strengthens strategic position in a multi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
